Sarepta Therapeutics (SRPT) Profit After Tax (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.29% |
| Dec 31, 2025 | -715.19% |
| Sep 30, 2025 | -125.68% |
| Jun 30, 2025 | 144.00% |
| Mar 31, 2025 | -381.36% |
| Dec 31, 2024 | 373.21% |
| Sep 30, 2024 | 420.29% |
| Jun 30, 2024 | -82.11% |
| Mar 31, 2024 | -20.89% |
| Dec 31, 2023 | 211.53% |
| Sep 30, 2023 | -71.00% |
| Jun 30, 2023 | 95.37% |
| Mar 31, 2023 | -373.03% |
| Dec 31, 2022 | 57.61% |
| Sep 30, 2022 | -11.34% |
| Jun 30, 2022 | -120.41% |
| Mar 31, 2022 | 13.90% |
| Dec 31, 2021 | -153.37% |
| Sep 30, 2021 | 40.86% |
| Jun 30, 2021 | 51.33% |
| Mar 31, 2021 | 11.66% |
| Dec 31, 2020 | 3.65% |
| Sep 30, 2020 | -30.29% |
| Jun 30, 2020 | -762.22% |
| Mar 31, 2020 | 92.58% |
| Dec 31, 2019 | -86.58% |
| Sep 30, 2019 | 54.30% |
| Jun 30, 2019 | -260.64% |
| Mar 31, 2019 | 45.60% |
| Dec 31, 2018 | -84.43% |
| Sep 30, 2018 | 30.09% |
| Jun 30, 2018 | -208.99% |
| Mar 31, 2018 | -47.36% |
| Dec 31, 2017 | 49.73% |
| Sep 30, 2017 | 24.29% |
| Jun 30, 2017 | -174.97% |
| Mar 31, 2017 | 195.07% |
| Dec 31, 2016 | -55.88% |
| Sep 30, 2016 | 8.92% |
| Jun 30, 2016 | -4.23% |
| Mar 31, 2016 | 7.59% |
| Dec 31, 2015 | -24.53% |
| Sep 30, 2015 | -24.10% |
| Jun 30, 2015 | 32.01% |
| Mar 31, 2015 | -38.60% |
| Dec 31, 2014 | -51.97% |
| Sep 30, 2014 | 13.72% |
| Jun 30, 2014 | -19.81% |
| Mar 31, 2014 | -220.56% |
| Dec 31, 2013 | 79.01% |
| Sep 30, 2013 | -120.62% |
| Jun 30, 2013 | 54.73% |
| Mar 31, 2013 | 32.20% |
| Dec 31, 2012 | -25.25% |
| Sep 30, 2012 | -716.50% |
| Jun 30, 2012 | 145.40% |
| Mar 31, 2012 | -1,155.60% |
| Dec 31, 2011 | 64.93% |
| Sep 30, 2011 | -414.31% |
| Jun 30, 2011 | -30.22% |
| Mar 31, 2011 | 211.02% |
| Dec 31, 2010 | 55.56% |
| Sep 30, 2010 | 51.22% |